Jacob Asset Management of New York’s Precision BioSciences DTIL Stock Holding History

Jacob Asset Management of New York’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$133K	Hold	13,014	–	–	0.19%	60
2023 Q2	$205K	Buy	13,014 +834	+7%	+$19.1K	0.23%	58
2023 Q1	$275K	Buy	12,180 +1,333	+12%	+$43.9K	0.32%	52
2022 Q4	$387K	Buy	10,847 +937	+9%	+$37K	0.47%	47
2022 Q3	$387K	Buy	9,910 +1,833	+23%	+$87.1K	0.42%	46
2022 Q2	$388K	Buy	8,077 +3,720	+85%	+$218K	0.39%	49
2022 Q1	$403K	Sell	4,357 -2,167	-33%	-$294K	0.25%	58
2021 Q4	$1.45M	Sell	6,524 -1,209	-16%	-$338K	0.65%	39
2021 Q3	$2.68M	Buy	7,733 +700	+10%	+$237K	0.97%	32
2021 Q2	$2.64M	Buy	7,033 +2,400	+52%	+$721K	0.87%	35
2021 Q1	$1.44M	Buy	4,633 +1,566	+51%	+$548K	0.56%	50
2020 Q4	$767K	Buy	+3,067	New	+$752K	0.58%	39

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

OMC

OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jacob Asset Management of New York's DTIL Position: Q3 2023 in Review

Jacob Asset Management of New York held its Precision BioSciences (DTIL) position steady in Q3 2023 at 13,014 shares worth $133K. The position accounts for 0.19% of the portfolio, ranked #60.

Jacob Asset Management of New York first reported a position in DTIL in Q4 2020 and has held it in 12 quarters since. The position peaked at $2.68M in Q3 2021. 76 funds tracked by Wall St. Rank hold DTIL as of Q3 2023.

Jacob Asset Management of New York held 13,014 shares of Precision BioSciences worth $133K as of Q3 2023.
Jacob Asset Management of New York left its Precision BioSciences share count unchanged in Q3 2023.
Precision BioSciences made up 0.19% of Jacob Asset Management of New York's portfolio in Q3 2023, its #60 holding.
Jacob Asset Management of New York first reported a position in Precision BioSciences in Q4 2020 and has held it in 12 quarters since.
Jacob Asset Management of New York's Precision BioSciences position peaked at $2.68M in Q3 2021.
76 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2023.

Based on Jacob Asset Management of New York's 13F filing for Q3 2023, filed 1 Nov 2023.